FDA Sheds Light On How It Will Gauge Pharmaceutical Quality During Inspections
Agency Says NIPP Protocols Will Be Expanded To Non-Sterile Drugs Next Year
Executive Summary
The US FDA announces plans to expand its new protocol-based approach to inspections, NIPP, to non-sterile drugs and provides glimpse of what metrics the agency is using to measure pharmaceutical quality during inspections.